Blood ,its products and transfusion

Slides:



Advertisements
Similar presentations
Coagulopathy and blood component transfusion in trauma
Advertisements

Blood Transfusion in The Neonate Dr.Boskabadi Neonatologist.
COMPONENT THERAPY IN MASSIVE OBSTETRIC HAEMORRHAGE Dr. Mona Shroff, M.D.(O&G) Dr. Mona Shroff, M.D.(O&G) 1 Dr Mona Shroff
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
Blood Components Dosage And Their Administration
BLOOD THERAPY. BLOOD PRODUCTS(1) Blood-cells products whole blood packed red blood cells leukocyte-poor (reduced) red cells washed red blood cells random-donor.
Faculty of Allied Medical Science
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U.
INDICATIONS FOR EMERGENT TRANSFUSIONS Manjushree Matadial DO Saint Joseph Hospital and Medical Center, April 27,2009.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
BLOOD BANKING 1- BLOOD PRODUCTS 2- AUTOLOGOUS TRANSFUSION M. H. Shaheen Maadi Armed Forces Hospital.
Blood Components.
MAXINE BOYD HOSPITAL TRANSFUSION PRACTITIONER
Cristy M. Thomas FNP-BC University of Nevada School of Medicine University Medical Center, Las Vegas NV Nevada’s Only Level 1 Adult Trauma, Level 2 Pediatric.
HAEMATOLOGY MODULE: COAGULATION DISORDERS 1 Adult Medical-Surgical Nursing.
D - DEATH I - IS C - COMING DIC is an important contributor to maternal mortality and morbidity.
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
4th year medical students Blood Component Therapy Salwa I Hindawi MSc FRCPath CTM Director of Blood Transfusion Services KAUH. Jeddah.
BLOOD TRANSFUSION Begashaw M (MD).
Senior clinician Request: a o 4 units RBC o 2 units FFP Consider: a o 1 adult therapeutic dose platelets o tranexamic acid in trauma patients Include:
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
TRANSFUSION MEDICINE MBBS,MCPS,FCPS. Professor of Pathology
Dr Ahmed abdulwahab. Hemorrhage is still one of the leading cause of maternal mortality all over the world DEFINITION Primary post partum hemorrhage.
BLOOD TRANSFUSION NUR 317. TRANSFUSION Infusion of blood products for the purpose of restoring circulating volume.
Blood Component Therapy
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
Transfusion Management of Massive Haemorrhage in Adults Patient bleeding / collapses Ongoing severe bleeding eg: 150 mls/min and Clinical shock Administer.
Whole Blood After transfusion with one unit of whole blood, 1.0g/dL hemoglobin indications for transfusion with whole blood are hemorrhagic shock with.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
Module 1: The Journey of Blood: Donation to Distribution Transfusion Training Workshop KKM 2012.
Lesson starter Once a protein has denatured, it cannot return to its original shape. Explain why. Haemoglobin is a protein found in the blood. Name two.
Preparation of blood components
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
General Surgery Mosul university- College of dentistry-oral & maxillofacial surgery department Dr. Ziad H. Delemi B.D.S, F.I.B.M.S (M.F.) Blood Transfusion.
Transfusion Medicine Kristine Krafts, M.D.. Blood groups Introduction ABO system Rh system Other systems Blood transfusion Blood products Indications.
Blood Transfusion Safe Practice.
Blood Groups and Blood Transfusion Dr Stuart Laidlaw Haematology Royal Hallamshire Hospital.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Blood Transfusion Products. Learning Objectives  To identify the products that can be derived from whole blood donations  To describe the conditions.
Blood and Blood Products. Whole Blood n Contents –RBC’s –WBC’s –Platelets –Plasma –Clotting factors.
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
BLOOD GROUPS AGGLUTINOGENS (Antigens) Complex oligosaccharide substances on the surface of the RBC membrane AGGLUTININS Antibodies against agglutinogens.
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
Blood Transfusion: It is best to AVOID it Dr. Syed Muhammad Irfan
The Blood Chapter 13.
Blood Made of Average person 4-6L 7.4 pH, acidosis if falls below 7.35
Blood Transfusions.
Blood Groups.
K A U H Blood bank Wesaam Al-Sheyyab.
Transfusion Medicine Kristine Krafts, M.D..
TRANSFUSION REACTIONS
BLOOD & BLOOD PRODUCTS.
Transfusion Medicine: Types, Indications and Complications
د.محمد حارث الساعاتي.
BLOOD GROUPS Blood groups are classified according to antigens on the membrane of RBCs called “Agglutinogen”, which are glycoprotein. The plasma may contain.
Transfusion Medicine Kristine Krafts, M.D..
COMPONENT THERAPY IN MASSIVE OBSTETRIC HAEMORRHAGE
Part 3.
BLOOD THERAPY.
Coagulation Disorders Importance in surgical practice
Transfusion Medicine Kristine Krafts, M.D..
Hematology and Coagulation Procedures
Drugs Affecting Blood.
کزین برتر اندیشه بر نگذرد
Blood transfusion Done by raghad farajat.
Dr. Kareema Ahmed Hussein
Blood Components Dosage And Their Administration
BLOOD TRANSFUSION Mary Vanderhoef MSN, ARNP
Presentation transcript:

Blood ,its products and transfusion By Dr.Mustafa Usama General and laparoscopic, endoscopic surgeon

Learning objects : To understand blood and its products . Indication of blood transfusion.with guide line for massive transfusion. Blood group and cross matching .ABO and Rheuses system . Complications of blood transfusion. Management of coagulopathy . DIC

Blood and blood products. The whole blood :Whole blood is now rarely available in civilian practice as it is an inefficient use of the limited resource. However, whole blood transfusion has significant advantages over packed cells as it is coagulation factor rich and, if fresh, more metabolically active than stored blood. Packed red cells Each unit is approximately 330 mL and has a haematocrit of 50–70 per cent. Packed cells are stored in a SAG-M solution (saline–adenine–glucose–mannitol) to increase shelf life to 5 weeks at 2–6°C.

Fresh-frozen plasma (FFP) is rich in coagulation factors and is removed from fresh blood and stored at −40 to −50°C with a two-year shelf life. It is the first-line therapy in the treatment of coagulopathic haemorrhage (see below under Management of coagulopathy). Rhesus D-positive FFP may be given to a rhesus D-negative woman.

Cryoprecipitate Cryoprecipitate is a supernatant precipitate of FFP and is rich in factor VIII and fibrinogen. It is stored at −30°C with a two year shelf life. It is given in low fibrinogen states or factor VIII deficiency. .

Platelets : Platelets are supplied as a pooled platelet concentrate and contain about 250 × 109/L. Platelets are stored on a special agitator at 20–24°C and have a shelf life of only 5 days. Platelet transfusions are given to patients with thrombocytopenia or with platelet dysfunction who are bleeding or undergoing surgery. Asprin .clpodigril ??vasopressin with continuous platelets infusion.

Prothrombin complex concentrates Prothrombin complex concentrates (PCC) are highly purified concentrates prepared from pooled plasma. They contain factorsII, IX and X. Factor VII may be included or produced separately.It is indicated for the emergency reversal of anticoagulant (warfarin)therapy in uncontrolled haemorrhage.

Autologous blood: Collection up to 3 weeks During same surgery , they collect blood and washed and then re transfuse.

Indication of blood transfusion acute blood loss, to replace circulating volume and maintain oxygen delivery. perioperative anaemia, to ensure adequate oxygen delivery during the perioperative phase. • symptomatic chronic anaemia, without haemorrhage or impending surgery.

Perioperative transfusion criteria Indication Hemoglobin level g/dl Probably will benefit from transfusion <6 Transfusion unlikely to be of benefit in the absence of bleeding or impending surgery 6-8 No indication for transfusion in the absence of other risk factors. >8

Blood group and cross matching Frequency (%) Antibodies Antigens Genotype Phenotype 46 AntiA,anti B O OO 42 Anti B A AA or AO 9 Anti A B BB or BO 3 None AB ABO system

Rhesus system 85% RH +ve 15% RH –ve Aquired during delivery RH-ve mother Next prenancy antibodies cross placenta and cause haemolytic aneamia and hydrop fetalis .

Complication of blood transfusion Complications from a single transfusion include: • incompatibility haemolytic transfusion reaction • febrile transfusion reaction(non-haemolytic ,leukocyte induce) • allergic reaction • infection : bacterial infection (usually due to faulty storage),hepatitis HIV, malaria. • air embolism • thrombophlebitis • transfusion-related acute lung injury (usually from FFP).(TRALI).IT is syndrome of transfusion of plasma part of blood .non cardiogenic pulmonary oedema .

Transfusion –associated circulatory overload :(TACO) It can occur with rapid infusion of blood, plasma expanders, and crystalloids, particularly in older patients with underlying heart disease. Central venous pressure monitoring should be considered.

Complications from massive transfusion • coagulopathy • hypocalcaemia • hyperkalaemia • hypokalaemia • hypothermia

The modern practice of ‘safe’ massive blood transfusion consists of: • replacing and maintaining blood volume by RBC packs: use stored blood less than 14 days old • haemostatic resuscitation by administering a 1:1:1 ratio (equal parts PRBCs, FFP and platelets); replaced volume maintaining hemostasis based on the coagulation screen (platelet count, thrombin time and prothrombin time).

• maintaining oxygen-carrying capacity: ensure PCV >20 or Hb >80›g/L (repeat hematological testing) • keeping the patient warm: heating coils on the blood circuit, heated blanket, etc. • correcting or avoiding metabolic complications • maintaining a normal plasma protein concentration: avoid excessive crystalloid infusions and monitor the plasma albumin level.

Management of coagulopathy • FFP if prothrombin time (PT) or partial thromboplastin time (PTT) >1.5 times normal. • cryoprecipitate if fibrinogen <0.8 g/L • platelets if platelet count <50 × 109/mL.

DIC DIC is an acquired syndrome characterized by systemic activation of coagulation pathways that result in excessive thrombin generation and the diffuse formation of microthrombi. This disturbance ultimately leads to consumption and depletion of platelets and coagulation factors with the resultant classic picture of diffuse Bleeding..

injuries resulting in embolization of materials such as brain matter, bone marrow, or amniotic fluid can act as potent thromboplastins that activate the DIC . Additional etiologies include malignancy, organ injury (such as severe pancreatitis), liver failure, certain vascular abnormalities (such as large aneurysms), snake bites, illicit drugs, transfusion reactions, transplant rejection, and sepsis

Diagnosis : Depend on inciting etiology with associated thrombocytopenia, prolongation of the prothrombin time, a low fibrinogen level, and elevated fibrin markers (FDPs, D-dimer, soluble fibrin monomers). Treatment :If there is active bleeding, hemostatic factors should be replaced with FFP, which is usuall ysufficient to correct the hypofibrinogenemia, although cryoprecipitate, fibrinogen concentrates, or platelet concentrates may also be needed.

Thank you for your lessening